It was inferred that RVT obstructs diabetes-induced RGC mortality through down regulating calmodulin-dependent protein kinase II (CaMKII), suggesting that RVT may have potential therapeutic implications for the prevention of diabetes-induced visual impairment (Kim et al., 2010). The gene discussed is CAMK2G; the disease is diabetes mellitus.